BECTON DICKINSON & Co (BDX) Com Stk USD 1

Sell:$248.81Buy:$249.00$2.08 (0.84%)

Prices delayed by at least 15 minutes
Sell:$248.81
Buy:$249.00
Change:$2.08 (0.84%)
Deal now
Prices delayed by at least 15 minutes
Sell:$248.81
Buy:$249.00
Change:$2.08 (0.84%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Key people

Thomas E. Polen
Chairman of the Board, President, Chief Executive Officer
Christopher J. Delorefice
Chief Financial Officer, Executive Vice President
Shana Carol Neal
Chief People Officer, Executive Vice President
Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Michelle Quinn
Executive Vice President, General Counsel
Richard Byrd
Executive Vice President, President - Interventional Segment
Michael Feld
Executive Vice President, President - Life Sciences
Michael Garrison
Executive Vice President, President - Medical Segment
Roland Goette
Executive Vice President, President - EMEA
Pavan Mocherla
Executive Vice President, President - Greater Asia
Bertram L. Scott
Lead Independent Director
William M. Brown
Independent Director
Catherine M. Burzik
Independent Director
Carrie L. Byington
Independent Director
Robert Andrew Eckert
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US0758871091
  • Market cap
    $72.24bn
  • Employees
    74,000
  • Shares in issue
    371.50m
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.